Skip to main content
Journal cover image

Correction to: Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer.

Publication ,  Journal Article
Sammons, S; Kornblum, NS; Blackwell, KL
Published in: Target Oncol
February 2019

The article Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer, written by Sarah Sammons, Noah S. Kornblum and Kimberly L. Blackwell, was originally published electronically on the publisher's internet portal (currently SpringerLink).

Duke Scholars

Published In

Target Oncol

DOI

EISSN

1776-260X

Publication Date

February 2019

Volume

14

Issue

1

Start / End Page

13

Location

France

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sammons, S., Kornblum, N. S., & Blackwell, K. L. (2019). Correction to: Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer. Target Oncol, 14(1), 13. https://doi.org/10.1007/s11523-018-0614-x
Sammons, Sarah, Noah S. Kornblum, and Kimberly L. Blackwell. “Correction to: Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer.Target Oncol 14, no. 1 (February 2019): 13. https://doi.org/10.1007/s11523-018-0614-x.
Sammons, Sarah, et al. “Correction to: Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer.Target Oncol, vol. 14, no. 1, Feb. 2019, p. 13. Pubmed, doi:10.1007/s11523-018-0614-x.
Journal cover image

Published In

Target Oncol

DOI

EISSN

1776-260X

Publication Date

February 2019

Volume

14

Issue

1

Start / End Page

13

Location

France

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis